NCT06894511
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06894511
Title An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC (PSMAndARPI)
Acronym PSMAndARPI
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Cancer And Blood Spclsts of AZ RECRUITING Casa Grande Arizona 85122 United States Details
Arizona Center for Cancer Care RECRUITING Gilbert Arizona 85297 United States Details
Highlands Oncology Group RECRUITING Fayetteville Arkansas 72703 United States Details
Hoag Memorial Hospital Presbyterian RECRUITING Newport Beach California 92663 United States Details
Univ Of Color Anschutz Med Center RECRUITING Aurora Colorado 80045 United States Details
Cancer Specialists of North Florida RECRUITING Jacksonville Florida 32256 United States Details
East Jefferson Hospital RECRUITING Metairie Louisiana 70006 United States Details
Urology Cancer Center PC RECRUITING Omaha Nebraska 68130 United States Details
Northwest Cancer Specialists RECRUITING Portland Oregon 97210 United States Details
Oregon Urology Institute RECRUITING Springfield Oregon 97477 United States Details
Texas Oncology P A RECRUITING Bedford Texas 76022 United States Details
Urology Austin RECRUITING Lakeway Texas 78738 United States Details
Urology San Antonio RECRUITING San Antonio Texas 78229 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field